|
|
|
|
Cancer Pain Treatment
BioDelivery gets approval to resume cancer pain treatment trials -- Sep 26, 2006
Reuters Research) on Tuesday said it received approval from the Research Advisory Panel of California for two clinical trial protocols for its cancer pain patch. ...
Fast-acting pain lozenge is approved -- Sep 26, 2006
Philadelphia Inquirer, Fentora is a successor cancer-pain treatment to Cephalon's Actiq, which faces lower-cost generic competition from Barr Laboratories at any time. ...
Cephalon's Fentora cancer pain drug OK'd -- Sep 27, 2006
Bizjournals.com, The Food and Drug Administration voted Monday night to approve Cephalon Inc.'s experimental cancer pain treatment drug called Fentora. ...
Fast-acting pain lozenge is approved -- Sep 26, 2006
Therapeutics Daily (subscription) (press release), ...hours trading. Fentora is a successor cancer-pain treatment to Cephalon's Actiq, which faces lower-cost generic competition ...
Drug Clearance Lifts Cephalon -- Sep 26, 2006
TheStreet.com October. Fentora, a tablet that dissolves in the mouth, is a successor to Actiq, a cancer-pain treatment in the form of a lollipop. ...
Cephalon Gets FDA Approval for Fentora -- Sep 26, 2006
Houston Chronicle, FRAZER, Pa. — Drug maker Cephalon Inc. has received Food and Drug Administration approval to market its cancer pain treatment Fentora. ...
ProStrakan 'on course for profitability' -- Sep 14, 2006
Edinburgh Evening News, ...of the current half also got off to a good start, with Pro- Strakan striking a deal with Hungarian firm Gedeon Richter to distribute cancer pain treatment ...
Archive for Cancer Pain Treatment :
Archive last updated July 7, 2005
|
|
|
